A-Med Health Care has sold its Specialty Pharmacy Division to Altamont Capital Partners
A-Med Health Care has sold its Specialty Pharmacy Division to Altamont Capital Partners (ACP) for an undisclosed consideration.
Specialty Pharmacy Division is A-Med's specialty pharmacy division providing healthcare distribution services for patients with chronic diseases through home delivery.
Altamont Capital Partners is a private equity firm based in the San Francisco Bay area with over US$1 billion in capital, focused on investing in change-intensive middle market businesses. They are particularly drawn to companies which are constrained for some reason from realizing their full potential, and they seek opportunities to work in partnership with management to implement strategic and operational change. ACP is a generalist firm with deep experience in several verticals including business services, financial services, industrials, healthcare, technology, consumer, retail and aerospace & defense sectors.
A-Med Health Care provides healthcare distribution services for patients with chronic diseases through home delivery. A-Med's mission is to provide excellent care and achieve positive outcomes for its clients through comprehensive, cost effective, and quality services. Enhancing the health and well being of its clients promotes wellness. Utilization of available resources, consumer surveys, staff involvement, state and federal regulations, recognition of community and industry needs, technology, education, self evaluation, leadership, and financial stability will promote this mission.
Oaklins' team in Los Angeles advised the seller. This transaction was for the specialty pharmacy component of the business only. This transaction was for the specialty pharmacy component of the business only.
Talk to the deal team
Gary Rabishaw
Oaklins Intrepid
Eduard Bagdasarian
Oaklins Intrepid
Jeremiah Mann
Oaklins Intrepid
Related deals
Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Learn moreDolmans Landscaping Group has welcomed Foreman Capital as a new shareholder to support further growth
Dolmans Landscaping Group, a leading full-service provider of landscaping services, has welcomed Foreman Capital as a new shareholder. By partnering with Foreman Capital, which has extensive experience in building stronger companies in the maintenance of public spaces, Dolmans can accelerate its growth trajectory across core verticals and further professionalize the business.
Learn moreNuzoa has acquired Agrofauna
Nuzoa, a provider of value-added services for pets and livestock in the Iberian Peninsula, has acquired 100% of Agrofauna. This transaction reinforces Nuzoa’s presence in the Portuguese market, particularly in the northern region, marking another step toward its ambition to become the leading operator while further consolidating its brand across Iberia.
Learn more